US Stock Futures Up Ahead Of Economic Data - bebe stores (OTC:BEBE)

Pre-open movers

US stock futures traded higher in early pre-market trade. The Empire State manufacturing index for December will be released at 8:30 a.m. ET, while industrial production data for November will be released at 9:15 a.m. ET. The NAHB housing market index for December will be released at 10:00 a.m. ET. Futures for the Dow Jones Industrial Average jumped 110 points to 17,301.00, while the Standard & Poor's 500 index futures rose 14.10 points to 2,004.50. Futures for the Nasdaq 100 index climbed 32.25 points to 4,218.00.

A Peek Into Global Markets

European markets were higher today, with the Spanish Ibex Index rising 0.74%, STOXX Europe 600 Index gaining 0.30%. German DAX 30 index climbed 0.31%, French CAC 40 Index rose 0.51% and London's FTSE 100 Index rose 0.36%. In Asian markets, Japan's Nikkei Stock Average fell 1.57%, Hong Kong's Hang Seng Index tumbled 0.95%, China's Shanghai Composite Index climbed 0.52% and India's Sensex slipped 0.11%.

Broker Recommendation

Analysts at Morgan Stanley upgraded Oracle

ORCL

from Equal-weight to Overweight. The price target for Oracle has been raised from $45.00 to $50.00. Oracle's shares closed at $39.95 on Friday.

Breaking news

Acorda Therapeutics ACOR today announced that the first patient has been enrolled in a Phase 3 clinical trial of dalfampridine for the treatment of post-stroke walking deficits (PSWD). To read the full news, click here.
bebe stores BEBE today announced that Jim Wiggett has been named Chief Executive Officer and appointed to the Company's Board of Directors, effective immediately. To read the full news, click here.
Emerson EMR today announced that it has agreed to sell its Power Transmission Solutions business unit to Regal Beloit RBC. To read the full news, click here.
DaVita HealthCare Partners DVA, one of the nation's largest and most innovative health care communities, today announced that two of its business units, DaVita Clinical Research (DCR) and HealthCare Partners Clinical Research, will merge capabilities to further expand its extensive clinical research and data analytics services, specifically in patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD), as well as primary care and chronic disease patients treated in an integrated care organization. To read the full news, click here.

Market News and Data brought to you by Benzinga APIs